<table id="id_e3f5e7c7-bc35-4e75-81f7-349d88cd9894" width="719.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_3414e04e-57bb-4338-998e-983199b2cdc3">Table 2: Incidence of Primary Endpoint Events</caption>
<col width="26.7%"></col>
<col width="9.2%"></col>
<col width="9.2%"></col>
<col width="9.2%"></col>
<col width="9.9%"></col>
<col width="11.3%"></col>
<col width="13.2%"></col>
<col width="11.4%"></col>
<thead>
<tr id="id_03744682-eb14-4f1f-81a3-5ed6d182d4ce">
<td align="left" stylecode="Botrule" valign="top">
<br/>
</td>
<td align="left" colspan="2" stylecode="Botrule" valign="top">Losartan</td>
<td align="left" colspan="2" stylecode="Botrule" valign="top">Atenolol</td>
<td align="left" stylecode="Botrule" valign="top">Risk <br/>Reduction<footnote id="id-0350c260-42c5-4393-a8a2-adc17fa26e6d">Adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy</footnote>
</td>
<td align="left" stylecode="Botrule" valign="top">95% <br/>CI</td>
<td align="left" stylecode="Botrule" valign="top">p-Value</td>
</tr>
</thead>
<tbody>
<tr id="id_7299735f-1e59-43d4-95bc-3850c576eb7f">
<td align="left" stylecode="Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode="Toprule" valign="top">N (%)</td>
<td align="left" stylecode="Toprule" valign="top">Rate<footnote id="id-d5f8b321-f468-4ef3-8db0-f129a8efb842">Rate per 1000 patient-years of follow-up</footnote>
</td>
<td align="left" stylecode="Toprule" valign="top">N (%)</td>
<td align="left" stylecode="Toprule" valign="top">Rate<footnoteref idref="id-d5f8b321-f468-4ef3-8db0-f129a8efb842"></footnoteref>
</td>
<td align="left" stylecode="Toprule" valign="top">
<br/>
</td>
<td align="left" stylecode="Toprule" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
</tr>
<tr id="id_f1910604-278a-44df-a852-414bd1f9cc3e">
<td align="left" stylecode="Botrule" valign="top">
<br/>Primary Composite Endpoint</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>508 (11)</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>23.8</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>588 (13)</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>27.9</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>13%</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>2% to 23%</td>
<td align="left" stylecode="Botrule" valign="top">
<br/>0.021</td>
</tr>
<tr id="id_e9507bc7-a8ee-4c35-8328-719a2c2b1491">
<td align="left" colspan="5" valign="top">
<br/>Components of Primary Composite Endpoint (as a first event)</td>
<td align="left" colspan="3" valign="top">
<br/>
</td>
</tr>
<tr id="id_8ac85c5d-abe2-43db-b2e8-3500523a5fd3">
<td align="left" valign="top">    Stroke (nonfatal<footnote id="id-63ca2cd2-4e86-431f-a90e-0008aa263a60">First report of an event, in some cases the patient died subsequently to the event reported</footnote>)</td>
<td align="left" valign="top">209 (5)</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">286 (6)</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
</tr>
<tr id="id_e1e23e99-a173-430f-a872-5977f15b15b3">
<td align="left" valign="top">    Myocardial infarction (nonfatal<footnoteref idref="id-63ca2cd2-4e86-431f-a90e-0008aa263a60"></footnoteref>)</td>
<td align="left" valign="top">174 (4)</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">168 (4)</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
</tr>
<tr id="id_7093f969-5a86-4d2b-b219-ce3c9732355d">
<td align="left" valign="top">    Cardiovascular mortality</td>
<td align="left" valign="top">125 (3)</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">134 (3)</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
<td align="left" valign="top">
<br/>
</td>
</tr>
<tr id="id_4f451658-f1f8-446a-9d66-9a6ddf59cab8">
<td align="left" colspan="5" valign="top">
<br/>Secondary Endpoints (any time in study)</td>
<td align="left" colspan="3" valign="top">
<br/>
</td>
</tr>
<tr id="id_a0d75c31-04ac-4860-8319-3748ef363e84">
<td align="left" valign="top">   Stroke (fatal/nonfatal)</td>
<td align="left" valign="top">232 (5)</td>
<td align="left" valign="top">10.8</td>
<td align="left" valign="top">309 (7)</td>
<td align="left" valign="top">14.5</td>
<td align="left" valign="top">25%</td>
<td align="left" valign="top">11% to 37%</td>
<td align="left" valign="top">0.001</td>
</tr>
<tr id="id_58d12d36-2679-4240-bcdb-8e33b3a0c4a3">
<td align="left" valign="top">   Myocardial infarction (fatal/nonfatal)</td>
<td align="left" valign="top">198 (4)</td>
<td align="left" valign="top">9.2</td>
<td align="left" valign="top">188 (4)</td>
<td align="left" valign="top">8.7</td>
<td align="left" valign="top">-7%</td>
<td align="left" valign="top">-13% to 12%</td>
<td align="left" valign="top">0.491</td>
</tr>
<tr id="id_46dc0bd1-83e3-4429-bc09-97b8cb9ea7d6">
<td align="left" valign="top">   Cardiovascular mortality</td>
<td align="left" valign="top">204 (4)</td>
<td align="left" valign="top">9.2</td>
<td align="left" valign="top">234 (5)</td>
<td align="left" valign="top">10.6</td>
<td align="left" valign="top">11%</td>
<td align="left" valign="top">-7% to 27%</td>
<td align="left" valign="top">0.206</td>
</tr>
<tr id="id_eac3d9e5-a913-400f-a2ce-1b918b32a1dc">
<td align="left" valign="top">     Due to CHD</td>
<td align="left" valign="top">125 (3)</td>
<td align="left" valign="top">5.6</td>
<td align="left" valign="top">124 (3)</td>
<td align="left" valign="top">5.6</td>
<td align="left" valign="top">-3%</td>
<td align="left" valign="top">-32% to 20%</td>
<td align="left" valign="top">0.839</td>
</tr>
<tr id="id_1af2e1b5-5175-40a1-bd35-dff3e5bacb5f">
<td align="left" valign="top">     Due to Stroke</td>
<td align="left" valign="top">40 (1)</td>
<td align="left" valign="top">1.8</td>
<td align="left" valign="top">62 (1)</td>
<td align="left" valign="top">2.8</td>
<td align="left" valign="top">35%</td>
<td align="left" valign="top">4% to 67%</td>
<td align="left" valign="top">0.032</td>
</tr>
<tr id="id_8bc20bba-122c-4d9e-85ef-2efa609d4074">
<td align="left" stylecode="Botrule" valign="top">     Other<footnote id="id-20a63401-5e2a-4be2-8b60-04523252585f">Death due to heart failure, non-coronary vascular disease, pulmonary embolism, or a cardiovascular cause other than stroke or coronary heart disease</footnote>
</td>
<td align="left" stylecode="Botrule" valign="top">39 (1)</td>
<td align="left" stylecode="Botrule" valign="top">1.8</td>
<td align="left" stylecode="Botrule" valign="top">48 (1)</td>
<td align="left" stylecode="Botrule" valign="top">2.2</td>
<td align="left" stylecode="Botrule" valign="top">16%</td>
<td align="left" stylecode="Botrule" valign="top">-28% to 45%</td>
<td align="left" stylecode="Botrule" valign="top">0.411</td>
</tr>
</tbody>
</table>